1,250
Views
80
CrossRef citations to date
0
Altmetric
Review Article

Nicotine: specific role in angiogenesis, proliferation and apoptosis

, , &
Pages 68-89 | Received 08 Apr 2011, Accepted 09 Sep 2011, Published online: 04 Nov 2011

References

  • Argentin G, Cicchetti R. (2006). Evidence for the role of nitric oxide in antiapoptotic and genotoxic effect of nicotine on human gingival fibroblasts. Apoptosis 11:1887–1897.
  • Arias HR, Richards VE, Ng D, Ghafoori ME, Le V, Mousa SA. (2009) Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis. Int J Biochem Cell Biol 41:1441–1451.
  • Arredondo J, Chernyavsky AI, Jolkovsky DL, Pinkerton KE, Grando SA. (2007). Receptor-mediated tobacco toxicity: Alterations of the NF-kB expression and activity downstream of alpha7 nicotinic receptor in oral keratinocytes. Life Sci 80:2191–2194.
  • Arredondo J, Chernyavsky AI, Marubio LM, Beaudet AL, Jolkovsky DL, Pinkerton KE, Grando SA. (2005). Receptor-mediated tobacco toxicity: regulation of gene expression through alpha3 beta2 nicotinic receptor in oral epithelial cells. Am J Pathol 166:597–613.
  • Banerjee AG, Gopalakrishnan VK, Vishwanatha JK. (2007). Inhibition of nitric oxide-induced apoptosis by nicotine in oral epithelial cells. Mol Cell Biochem 305:113–121.
  • Banerjee C, Nyengaard JR, Wevers A, de Vos RA, Jansen Steur EN, Lindstrom J, Pilz K, Nowacki S, Bloch W, Schröder H.,Banerjee C, Nyengaard JR, Wevers A. (2000). Cellular expression of alpha7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer’s and Parkinson’s disease − a stereological approach. Neurobiol Dis 7:666–672.
  • Bartol TM, Land BR, Salpeter EE., Salpeter MM. (1991). Monte-Carlo simulation of miniature end-plate current generation in the vertebrate neuromuscular junction. Biophys J 59:1290–1307.
  • Bastian LA. (2008). Smoking cessation for hospital patient: an opportunity to increase the reach of effective smoking cessation programs. J Gen Intern Med 23:1286–1287.
  • Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT. (1993). Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13:4181–4192.
  • Benowitz NL, Jacob P 3rd. (1984). Nicotine and carbon monoxide intake from high- and low-yield cigarettes. Clin Pharmacol Ther 36:265–270.
  • Benowitz NL. (2010). Nicotine addiction. N Engl J Med 362:2295–2303.
  • Beraldo FH, Arantes CP, Santos TG, Queiroz NG, Young K, Rylett RJ, Markus RP, Prado MA, Martins VR. (2010). Role of alpha7 nicotinic acetylcholine receptor in calcium signaling induced by prion protein interaction with stress-inducible protein 1. J Biol Chem 285:36542–36550.
  • Berger MR, Zeller WJ. (1988). Interaction of nicotine with anticancer treatment. Klin Wochenschr. 66 Suppl 11:127–133.
  • Bitner RS, Nikkel AL, Markosyan S, Otte S, Puttfarcken P, Gopalakrishnan M. (2009). Selective alpha7 nicotinic acetylcholine receptor activation regulates glycogen synthase kinase3beta and decreases tau phosphorylation in vivo. Brain Res 1265:65–74.
  • Bordia T, Campos C, Huang LZ, Quik M. (2008). Continuous and intermittent nicotine treatment reduces L-DOPA-induced dyskinesias in a rat model of Parkinson’s disease. J Pharmacol Exp Ther 327:239–247.
  • Bordia T, Grady SR, McIntosh JM, Quik M. (2007). Nigrostriatal damage preferentially decreases a subpopulation of {alpha}6{beta}2* nAChRs in mouse, monkey and Parkinson’s disease striatum. Mol Pharmacol 72:52–61.
  • Bossi SR, Simpson JR, Isacson O. (1993). Age dependence of striatal neuronal death caused by mitochondrial dysfunction. Neuroreport 4:73–76.
  • Brenner DE, Kukull WA, van Belle G, Bowen JD, McCormick WC, Teri L, Larson EB. (1993). Relationship between cigarette smoking and Alzheimer’s disease in a population-based case-control study. Neurology 43:293–300.
  • Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, Skingley P, Levine MN. (1993). Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 328:159–163.
  • Bruchfeld A, Goldstein RS, Chavan S, Patel NB, Rosas-Ballina M, Kohn N, Qureshi AR, Tracey KJ. (2010). Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritis. J Intern Med 268:94–101.
  • Bschleipfer T, Schukowski K, Weidner W, Grando SA, Schwantes U, Kummer W, Lips KS. (2007). Expression and distribution of cholinergic receptors in the human urothelium. Life Sci 80:2303–2307.
  • Buccafusco JJ, Beach JW, Terry AV Jr. (2009). Desensitization of nicotinic acetylcholine receptors as a strategy for drug development. J Pharmacol Exp Ther 328:364–370.
  • Calleja-Macias IE, Kalantari M, Bernard HU. (2009). Cholinergic signaling through nicotinic acetylcholine receptors stimulates the proliferation of cervical cancer cells: an explanation for the molecular role of tobacco smoking in cervical carcinogenesis? Int J Cancer 124:1090–1096.
  • Carmeliet P, Jain RK. (2000). Angiogenesis in cancer and other diseases. Nature 407:249–257.
  • Catassi A, Servent D, Paleari L, Cesario A, Russo P. (2008). Multiple roles of nicotine on cell proliferation and inhibition of apoptosis: implications on lung carcinogenesis. Mutat Res 659:221–231.
  • Chen AM, Jennelle RL, Grady V, Tovar A, Bowen K, Simonin P, Tracy J, McCrudden D, Stella JR, Vijayakumar S. (2009). Prospective study of psychosocial distress among patients undergoing radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 73:187–193.
  • Chen RJ, Ho YS, Guo HR, Wang YJ. (2010a). Long-term nicotine exposure-induced chemoresistance is mediated by activation of Stat3 and downregulation of ERK1/2 via nAChR and beta-adrenoceptors in human bladder cancer cells. Toxicol Sci 115:118–130.
  • Chen L, Wang H, Zhang Z, Li Z, He D, Sokabe M, Chen L. (2010b). DMXB (GTS-21) ameliorates the cognitive deficits in beta amyloid(25-35(-)) injected mice through preventing the dysfunction of alpha7 nicotinic receptor. J Neurosci Res 88:1784–1794.
  • Chen L, Yamada K, Nabeshima T, Sokabe M. (2006). alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats. Neuropharmacology 50:254–268.
  • Cheng K, Zimniak P, Raufman JP. (2003). Transactivation of the epidermal growth factor receptor mediates cholinergic agonist-induced proliferation of H508 human colon cancer cells. Cancer Res 63:6744–6750.
  • Chernyavsky AI, Arredondo J, Marubio LM, Grando SA. (2004). Differential regulation of keratinocyte chemokinesis and chemotaxis through distinct nicotinic receptor subtypes. J Cell Sci 117:5665–5679.
  • Chin JH, Tse FW, Harris K, Jhamandas JH. (2006). Beta-amyloid enhances intracellular calcium rises mediated by repeated activation of intracellular calcium stores and nicotinic receptors in acutely dissociated rat basal forebrain neurons. Brain Cell Biol 35:173–186.
  • Chipitsyna G, Gong Q, Anandanadesan R, Alnajar A, Batra SK, Wittel UA, Cullen DM, Akhter MP, Denhardt DT, Yeo CJ, Arafat HA. (2009). Induction of osteopontin expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cells. Int J Cancer 125:276–285.
  • Clunes LA, Bridges A, Alexis N, Tarran R. (2008). In vivo versus in vitro airway surface liquid nicotine levels following cigarette smoke exposure. J Anal Toxicol 32:201–207.
  • Cooke JP, Bitterman H. (2004). Nicotine and angiogenesis: a new paradigm for tobacco-related diseases. Ann Med 36:33–40.
  • Cooke JP, Ghebremariam YT. (2008). Endothelial nicotinic acetylcholine receptors and angiogenesis. Trends Cardiovasc Med 18:247–253.
  • Cooke JP. (2007). Angiogenesis and the role of the endothelial nicotinic acetylcholine receptor. Life Sci 80:2347–2351.
  • Costa F, Soares R. (2009). Nicotine: a pro-angiogenic factor. Life Sci 84:785–790.
  • Costenbader KH, Chang SC, De VI, R., Plenge, Karlson EW. (2008). Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene–environment interactions with heavy cigarette smoking, Arthritis Res Ther 10:R52.
  • Cox LS, Africano NL, Tercyak KP, Taylor KL. (2003). Nicotine dependence treatment for patients with cancer. Cancer 98:632–644.
  • Dajas-Bailador F, Wonnacott S. (2004). Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol Sci 25:317–324.
  • Dasgupta P, Chellappan SP. (2006a). Nicotine-mediated cell proliferation and angiogenesis: new twists to an old story. Cell Cycle 5:2324–2328.
  • Dasgupta P, Rastogi S, Pillai S, Ordonez-Ercan D, Morris M, Haura E, Chellappan S. (2006b). Nicotine induces cell proliferation by beta-arrestin-mediated activationof Src and Rb-Raf-1 pathways. J Clin Invest 116:2208–2217.
  • Dasgupta P, Kinkade R, Joshi B, Decook C, Haura E, Chellappan S. (2006). Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci USA 103:6332–6337.
  • Dasgupta P, Rizwani W, Pillai S, Kinkade R, Kovacs M, Rastogi S, Banerjee S, Carless M, Kim E, Coppola D, Haura E, Chellappan S. (2009). Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines. Int J Cancer 124:36–45.
  • Davis R, Rizwani W, Banerjee S, Kovacs M, Haura E, Coppola D, Chellappan S. (2009). Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS One 4(10):e7524.
  • de Jong PT. (2006). Age-related macular degeneration. N Engl J Med 355:1474–1485.
  • De Rosa MJ, Dionisio L, Agriello E, Bouzat C, Esandi Mdel C. (2009). Alpha 7 nicotinic acetylcholine receptor modulates lymphocyte activation. Life Sci 85:444–449.
  • Dom AM, Buckley AW, Brown KC, Egleton RD, Marcelo AJ, Proper NA, Weller DE, Shah YH, Lau JK, Dasgupta P. (2010). The {alpha}7-nicotinic acetylcholine receptor and MMP-2/9 pathway mediate the pro-angiogenic effect of nicotine in human retinal endothelial cells. Invest Ophthalmol Vis Sci. Jun 16. [Epub ahead of print].
  • Dunbar GC, Kuchibhatla RV, Lee G; TC-1734 (AZD3480) AAMI Clinical Study Group (USA). (2011). A randomized double-blind study comparing 25 and 50 mg TC-1734 (AZD3480) with placebo, in older subjects with age-associated memory impairment. J Psychopharmacol (Oxford) 25:1020–1029.
  • Dwyer JB, Broide RS, Leslie FM. (2008). Nicotine and brain development. Birth Defects Res C Embryo Today 84:30–44.
  • Dziewczapolski G, Glogowski CM, Masliah E, Heinemann SF (2009). Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer’s disease. J Neurosci 29:8805–8815.
  • Eddins D, Klein RC, Yakel JL, Levin ED. (2009). Hippocampal infusions of apolipoprotein E peptides induce long-lasting cognitive impairment. Brain Res Bull 79:111–115.
  • Egleton RD, Brown KC, Dasgupta P. (2008). Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci 29:151–158.
  • Egleton RD, Brown KC, Dasgupta P. (2009). Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases. Pharmacol Ther 121:550–553.
  • Evans JR, Fletcher AE, Wormald RP. (2005). 28,000 Cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking. Br J Ophthalmol 89:550–553.
  • Faghih R, Gopalakrishnan M, Briggs CA. (2008). Allosteric modulators of the alpha7 nicotinic acetylcholine receptor. J Med Chem 51:701–712.
  • Fang MA, Frost PJ, Iida-Klein A, Hahn TJ. (1991). Effects of nicotine on cellular function in UMR 106-01 osteoblast-like cells. Bone 12:283–286.
  • Feng S, Kapur S, Sarkar M, Muhammad R, Mendes P, Newland K, Roethig HJ. (2007). Respiratory retention of nicotine and urinary excretion of nicotine and its five major metabolites in adult male smokers. Toxicol Lett 173:101–106.
  • Fleming P, Blair PS. (2007). Sudden infant death syndrome and parental smoking. Early Hum Dev 83:721–725.
  • Folkman J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27–31.
  • Fortin A, Wang CS, Vigneault E. (2009). Influence of smoking and alcohol drinking behaviors on treatment outcomes of patients with squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 74:1062–1069.
  • Frazer-Abel AA, Baksh S, Fosmire SP, Willis D, Pierce AM, Meylemans H, Linthicum DS, Burakoff SJ, Coons T, Bellgrau D, Modiano JF. (2004). Nicotine activates nuclear factor of activated T cells c2 (NFATc2) and prevents cell cycle entry in T cells. J Pharmacol Exp Ther 311:758–769.
  • Fried PA, James DS, Watkinson B. (2001). Growth and pubertal milestones during adolescence in offspring prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol 23:431–436.
  • Frölich L, Ashwood T, Nilsson J, Eckerwall G; Sirocco Investigators. (2011). Effects of AZD3480 on cognition in patients with mild-to-moderate Alzheimer’s disease: a phase IIb dose-finding study. J Alzheimers Dis 24:363–374.
  • Fu XW, Lindstrom J, Spindel ER. (2009). Nicotine activates and up-regulates nicotinic acetylcholine receptors in bronchial epithelial cells. Am J Respir Cell Mol Biol 41:93–99.
  • Fucile S. (2004). Ca2+ permeability of nicotinic acetylcholine receptors. Cell Calcium 35:1–8.
  • Gao J, Xu H, Weinberg C, Huang X, Park Y, Hollenbeck A, Blair A, Schatzkin A, Burch L, Chen H. (2011). An Exploratory Study on the CHRNA3-CHRNA5-CHRNB4 Cluster, Smoking, and Parkinson’s Disease. Neurodegener Dis Jan 13. [Epub ahead of print].
  • Gemenetzidis E, Bose A, Riaz AM, Chaplin T, Young BD, Ali M, Sugden D, Thurlow JK, Cheong SC, Teo SH, Wan H, Waseem A, Parkinson EK, Fortune F, Teh MT. (2009). FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation. PLoS One. 4:e4849.
  • Gentry CL, Lukas RJ. (2002). Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure. Curr Drug Targets CNS Neurol Disord 1:359–385.
  • Gnecchi M, Zhang Z, Ni A, Dzau VJ. (2008). Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103:1204–1219.
  • Govind AP, Vezina P, Green WN. (2009). Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction. Biochem Pharmacol 78:756–765.
  • Grando SA, Kist DA, Qi M, Dahl MV. (1993). Human keratinocytes synthesize, secrete, and degrade acetylcholine. J Invest Dermatol 101:32–36.
  • Gregory RL, Gfell LE. (1996). Effect of nicotine on secretory component synthesis by secretory epithelial cells. Clin Diagn Lab Immunol 3:578–583.
  • Guan ZZ, Zhang X, Ravid R, Nordberg A. (2000). Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer’s disease. J Neurochem 74:237–243.
  • Gupta GP, Nguyen DX, Chiang AC, Bos PD, Kim JY, Nadal C, Gomis RR, Manova-Todorova K, Massagué J.(2007). Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 446:765–770.
  • Gyermek L. (1996). New local anesthetic agents. Anesthesiology 85:226–227.
  • Hanahan D, Folkman J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364.
  • Hawkins BT, Abbruscato TJ, Egleton RD, Brown RC, Huber JD, Campos CR, Davis TP. (2004). Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Res. 1027:48–58.
  • Heeschen C, Jang JJ, Weis M, Pathak A, Kaji S, Hu RS, Tsao PS, Johnson FL, Cooke JP. (2001). Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 7:833–839.
  • Heeschen C, Weis M, Aicher A, Dimmeler S, Cooke JP. (2002). A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest 110:527–536.
  • Heeschen C, Weis M, Cooke JP. (2003). Nicotine promotes arteriogenesis. J Am Coll Cardiol 41:489–496.
  • Hellstrom-Lindahl E, Mousavi M, Zhang X, Ravid R, Nordberg A. (1999). Regional distribution of nicotinic receptor subunit mRNA in human brain: Comparison between Alzheimer and normal brain. Mol Brain Res 66:94–103.
  • Hernandez CM, Kayed R, Zheng H, Sweatt JD, Dineley KT. (2010). Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer’s disease. J Neurosci 30:2442–2453.
  • Hillier V, Salib E. (1997). A case–control study of smoking and Alzheimer’s disease. Int J Geriatr Psychiatry 12:295–300.
  • Hogg RC, Raggenbass M, Bertrand D. (2003). Nicotinic acetylcholine receptors: from structure to brain function. Rev Physiol Biochem Pharmacol 147:1–46.
  • Hu M, Waring JF, Gopalakrishnan M, Li J. (2008). Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cells. J Neurochem 106:1371–1377.
  • Huang L, Parameswaran N, Bordia T, McIntosh JM, Quik M. (2009). Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys. J Neurochem 109:826–837.
  • Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Chen C, Goodman G, Field JK, Liloglou T, Xinarianos G, Cassidy A, McLaughlin J, Liu G, Narod S, Krokan HE, Skorpen F, Elvestad MB, Hveem K, Vatten L, Linseisen J, Clavel-Chapelon F, Vineis P, Bueno-de-Mesquita HB, Lund E, Martinez C, Bingham S, Rasmuson T, Hainaut P, Riboli E, Ahrens W, Benhamou S, Lagiou P, Trichopoulos D, Holcátová I, Merletti F, Kjaerheim K, Agudo A, Macfarlane G, Talamini R, Simonato L, Lowry R, Conway DI, Znaor A, Healy C, Zelenika D, Boland A, Delepine M, Foglio M, Lechner D, Matsuda F, Blanche H, Gut I, Heath S, Lathrop M, Brennan P. (2008). A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452:633–637.
  • Improgo MR, Tapper AR, Gardner PD. (2011). Nicotinic acetylcholine receptor-mediated mechanisms in lung cancer. Biochem Pharmacol 82:1015–1021.
  • International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 83: Tobacco smoke and involuntary smoking. Lyon (France): IARC; 2004.
  • Jacobi J, Jang JJ, Sundram U, Dayoub H, Fajardo LF, Cooke JP. (2002). Nicotine accelerates angiogenesis and wound healing in genetically diabetic mice. Am J Pathol 161:97–104.
  • Jin Z, Gao F, Flagg T, Deng X. (2004). Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation. J Biol Chem 279:40209–40219.
  • Jones GM, Sahakian BJ, Levy R, Warburton DM, Gray JA. (1992). Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer’s disease. Psychopharmacology (Berl) 108:485–494.
  • Karimi K, Bienenstock J, Wang L, Forsythe P. (2010). The vagus nerve modulates CD4+ T cell activity. Brain Behav Immun 24:316–323.
  • Kaur-Knudsen D, Bojesen SE, Tybjærg-Hansen A, Nordestgaard BG. (2011). Nicotinic acetylcholine receptor polymorphism, smoking behavior, and tobacco-related cancer and lung and cardiovascular diseases: a cohort study.J Clin Oncol 29:2875–2882.
  • Khan JC, Thurlby DA, Shahid H, Clayton DG, Yates JR, Bradley M, Moore AT, Bird AC. (2006). Genetic Factors in AMD Study. Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol 90:75–80.
  • Kihara T, Shimohama S, Sawada H, Honda K, Nakamizo T, Shibasaki H, Kume T, Akaike A (2001). Alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. J Biol Chem 276:13541–13546.
  • Kim LC, Song L, Haura EB. (2009). Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol 6:587–595.
  • Kishi M, Steinbach JH. (2006). Role of the Agonist Binding Site in Up-Regulation of Neuronal Nicotinic α4β2 Receptors. Mol Pharmacol 70:2037–2044.
  • Kiuchi K, Matsuoka M, Wu JC, Lima e Silva R, Kengatharan M, Verghese M, Ueno S, Yokoi K, Khu NH, Cooke JP, Campochiaro PA. (2008). Mecamylamine suppresses Basal and nicotine-stimulated choroidal neovascularization. Invest Ophthalmol Vis Sci 49:1705–1711.
  • Kondo T, Hayashi M, Takeshita K, Numaguchi Y, Kobayashi K, Iino S, Inden Y, Murohara T. (2004). Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 24:1442–1447.
  • Konishi H, Wu J, Cooke JP. (2010). Chronic exposure to nicotine impairs cholinergic angiogenesis. Vasc Med 15:47–54.
  • Kumar B, Cordell KG, Lee JS, Worden FP, Prince ME, Tran HH, Wolf GT, Urba SG, Chepeha DB, Teknos TN, Eisbruch A, Tsien CI, Taylor JM, D’Silva NJ, Yang K, Kurnit DM, Bauer JA, Bradford CR, Carey TE. (2008). EGFR, p16, HPV titer, bcl-xL, and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 26:3128–3137.
  • Kummer W, Lips KS, Pfeil U. (2008). The epithelial cholinergic system of the airways. Histochem Cell Biol 130:219–234.
  • Lainer-Carr D, Brahn E. (2007). Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis. Nat Clin Pract Rheumatol 3:434–442.
  • Lane D, Gray EA, Mathur RS, Mathur SP. (2005). Up-regulation of vascular endothelial growth factor-C by nicotine in cervical cancer cell lines. Am J Reprod Immunol 53:153–158.
  • Lee CH, Huang CS, Chen CS, Tu SH, Wang YJ, Chang YJ, Tam KW, Wei PL, Cheng TC, Chu JS, Chen LC, Wu CH, Ho YS. (2010). Overexpression and activation of the alpha9-nicotinic receptor during tumorigenesis in human breast epithelial cells. J Natl Cancer Inst 102:1322–1335.
  • Lee DH, Wang HY. (2003). Differential physiologic responses of alpha7 nicotinic acetylcholine receptors to beta-amyloid 1-40 and beta-amyloid 1-42. J Neurobiol 55:25–30.
  • Lee J, Laurin N, Crosbie J, Ickowicz A, Pathare T, Malone M, Kennedy JL, Tannock R, Schachar R, Barr CL. (2008). Association study of the nicotinic acetylcholine receptor alpha4 subunit gene, CHRNA4, in attention-deficit hyperactivity disorder. Genes Brain Behav 7:53–60.
  • Lester HA, Xiao C, Srinivasan R, Son CD, Miwa J, Pantoja R, Banghart MR, Dougherty DA, Goate AM, Wang JC. (2009). Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery. AAPS J 11:167–177.
  • Li XW, Wang H. (2006). Non-neuronal nicotinic alpha 7 receptor, a new endothelial target for revascularization. Life Sci 78:1863–1870.
  • Lieberman E, Torday J, Barbieri R, Cohen A, Van Vunakis H, Weiss ST. (1992). Association of intrauterine cigarette smoke exposure with indices of fetal lung maturation. Obstet Gynecol 79:564–570.
  • Linnoila I. (2010). From Nicotine to Breast Cancer, Implications of Cholinergic Receptor Pathway J Natl Cancer Inst 102:1298–1299.
  • Liu Q, Zhang J, Zhu H, Qin C, Chen Q, Zhao B. (2007). Dissecting the signaling pathway of nicotine-mediated neuroprotection in a mouse Alzheimer disease model. FASEB J 21:61–73.
  • Macklin KD, Maus AD, Pereira EF, Albuquerque EX, Conti-Fine BM. (1998). Human vascular endothelial cells express functional nicotinic acetylcholine receptors. J Pharmacol Exp Ther. 287: 435–439.
  • Mai H, May WS, Gao F, Jin Z, Deng X. (2003). A functional role for nicotine in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem 278:1886–1891.
  • Maneckjee R, Minna JD. (1994). Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. Cell Growth Differ 5:1033–1040.
  • Maneckjee R, Minna JD. (1990). Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc Natl Acad Sci USA 87:3294–3298.
  • Maouche K, Polette M, Jolly T, Medjber K, Cloëz-Tayarani I, Changeux JP, Burlet H, Terryn C, Coraux C, Zahm JM, Birembaut P, Tournier JM. (2009). {alpha}7 nicotinic acetylcholine receptor regulates airway epithelium differentiation by controlling basal cell proliferation. Am J Pathol 175:1868–1882.
  • Marrero MB, Bencherif M. (2009). Convergence of alpha 7 nicotinic acetylcholine receptor-activated pathways for anti-apoptosis and anti-inflammation: central role for JAK2 activation of STAT3 and NF-kappaB. Brain Res 1256:1–7.
  • Mathur RS, Mathur SP, Young RC. (2000). Up-regulation of epidermal growth factor-receptors (EGF-R) by nicotine in cervical cancer cell lines: this effect may be mediated by EGF. Am J Reprod Immunol 44:114–120.
  • Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, Gardiner PS, Grady SR, Heberlein U, Leonard SS, Levin ED, Lukas RJ, Markou A, Marks MJ, McCallum SE, Parameswaran N, Perkins KA, Picciotto MR, Quik M, Rose JE, Rothenfluh A, Schafer WR, Stolerman IP, Tyndale RF, Wehner JM, Zirger JM. (2007). Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) 190:269–319.
  • Mazhari NJ, Mandal AK, Thusoo TK. (2003). Carcinogenic effect of nicotine on normal mammary ductal epithelial cells and the protective role of beta-carotene. Indian J Pathol Microbiol 46:24–27.
  • McCartney JS, Fried PA, Watkinson B. (1994). Central auditory processing in school-age children prenatally exposed to cigarette smoke. Neurotoxicol Teratol 16:269–276.
  • Mei J, Hu H, McEntee M, Plummer H III, Song P, Wang HC. (2003). Transformation of non-cancerous human breast epithelial cell line MCF10A by the tobacco-specific carcinogen NNK. Breast Cancer Res Treat 79:95–105.
  • Meyer F, Bairati I, Fortin A, Gélinas M, Nabid A, Brochet F, Têtu B. (2008). Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients. Int J Cancer 122:1679–1683.
  • Michaelson JE, Ritzenthaler JD, Roman J. (2002). Regulation of serum-induced fibronectin expression by protein kinases, cytoskeletal integrity, and CREB. Am J Physiol Lung Cell Mol Physiol 282:L291–L301.
  • Misery L. (2004). Nicotine effects on skin: are they positive or negative? Exp Dermatol 13:665–670.
  • Mitsis EM, Cosgrove KP, Staley JK, Bois F, Frohlich EB, Tamagnan GD, Estok KM, Seibyl JP, van Dyck CH. (2009). Age-related decline in nicotinic receptor availability with [(123)I]5-IA-85380 SPECT. Neurobiol Aging 30:1490–1497.
  • Mousa S, Mousa SA. (2006). Cellular and molecular mechanisms of nicotine’s pro-angiogenesis activity and its potential impact on cancer. J Cell Biochem 97:1370–1378.
  • Mullen G, Napier J, Balestra M, DeCory T, Hale G, Macor J, Mack R, Loch J 3rd, Wu E, Kover A, Verhoest P, Sampognaro A, Phillips E, Zhu Y, Murray R, Griffith R, Blosser J, Gurley D, Machulskis A, Zongrone J, Rosen A, Gordon J. (2000). (-)-Spiro[1-azabicyclo[2.2.2]octane-3,59-oxazolidin-29-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the α 7 nicotinic acetylcholine receptor. J Med Chem 43:4045–4050.
  • Ndisang D, Khan A, Lorenzato F, Sindos M, Singer A, Latchman DS. (2010). The cellular transcription factor Brn-3a and the smoking-related substance nicotine interact to regulate the activity of the HPV URR in the cervix. Oncogene 29:2701–2711.
  • Nel AE, Slaughter N. (2002). T cell activation through the antigen receptor. Part 2. Role of signaling cascades in T cell differentiation, anergy, immune senescence,and development of immunotherapy. J. Allergy Clin. Immunol 109:901–915.
  • Newhouse PA, Potter A, Corwin J, Lenox R. (1992). Acute nicotinic blockade produces cognitive impairment in normal humans. Psychopharmacology (Berl) 108:480–484.
  • Ng MK, Wu J, Chang E, Wang BY, Katzenberg-Clark R, Ishii-Watabe A, Cooke JP. (2007). A central role for nicotinic cholinergic regulation of growth factor-induced endothelial cell migration. Arterioscler Thromb Vasc Biol 27:106–112.
  • Nizri E, Irony-Tur-Sinai M, Lory O, Orr-Urtreger A, Lavi E, Brenner T. (2009). Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J Immunol 183:6681–6688.
  • Nooyens AC, van Gelder BM, Verschuren WM. (2008). Smoking and cognitive decline among middle-aged men and women: the Doetinchem Cohort Study. Am J Public Health 98:2244–2250.
  • Oddo S, Caccamo A, Green KN, Liang K, Tran L, Chen Y, Leslie FM, LaFerla FM. (2005). Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer’s disease. Proc Natl Acad Sci USA 102:3046–3051.
  • Oloris SC, Frazer-Abel AA, Jubala CM, Fosmire SP, Helm KM, Robinson SR, Korpela DM, Duckett MM, Baksh S, Modiano JF. (2010). Nicotine-mediated signals modulate cell death and survival of T lymphocytes. Toxicol Appl Pharmacol 242:299–309.
  • Onoda N, Nehmi A, Weiner D, Mujumdar S, Christen R, Los G. (2001). Nicotine affects the signaling of the death pathway, reducing the response of head and neck cancer cell lines to DNA damaging agents. Head Neck 23:860–870.
  • O’Reilly EJ, McCullough ML, Chao A, Henley SJ, Calle EE, Thun MJ, Ascherio A. (2005). Smokeless tobacco use and the risk of Parkinson’s disease mortality. Mov Disord 20:1383–1384.
  • Paleari L, Cesario A, Fini M, Russo P. (2009). alpha7-Nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and Mesothelioma? Drug Discov Today 14:822–836.
  • Paleari L, Grozio A, Cesario A, Russo P. (2008). The cholinergic system and cancer. Semin Cancer Biol 18:211–217.
  • Papke RL, Porter Papke JK, Rose GM. (2004). Activity of alpha7-selective agonists at nicotinic and serotonin 5HT3 receptors expressed in Xenopus oocytes. Bioorg Med Chem Lett 14:1849–1853.
  • Papke RL, Stokes C, Williams DK, Wang J, Horenstein NA. (2011). Cysteine accessibility analysis of the human alpha7 nicotinic acetylcholine receptor ligand-binding domain identifies L119 as a gatekeeper. Neuropharmacology 60:159–171.
  • Park YJ, Lee T, Ha J, Jung IM, Chung JK, Kim SJ. (2008). Effect of nicotine on human umbilical vein endothelial cells (HUVECs) migration and angiogenesis. Vascul Pharmacol 49:32–36.
  • Parnavelas JG, Kelly W, Burnstock G. (1985). Ultrastructural localization of choline acetyltransferase in vascular endothelial cells in rat brain. Nature 316:724–725.
  • Pavlov VA, Tracey KJ. (2005). The cholinergic anti-inflammatory pathway. Brain Behav Immun 19:493–499.
  • Perry EK, Morris CM, Court JA, Cheng A, Fairbairn AF, McKeith IG, Irving D, Brown A, Perry RH. (1995). Alteration in nicotine binding sites in Parkinson’s disease, Lewy body dementia and Alzheimer’s disease: possible index of early neuropathology. Neuroscience 64:385–395.
  • Petrakis S, Irinopoulou T, Panagiotidis CH, Engelstein R, Lindstrom J, Orr-Urtreger A, Gabizon R, Grigoriadis N, Sklaviadis T. (2008). Cellular prion protein co-localizes with nAChR beta4 subunit in brain and gastrointestinal tract. Eur J Neurosci 27:612–620.
  • Picciotto MR, Zoli M. (2008). Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. Front Biosci 13:492–504.
  • Pierce JP, Messer K, White MM, Cowling DW, Thomas DP. (2011). Prevalence of heavy smoking in California and the United States, 1965–2007. JAMA 305:1106–1112.
  • Potter A, Corwin J, Lang J, Piasecki M, Lenox R, Newhouse PA. (1999). Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer’s disease. Psychopharmacology 142:334–342.
  • Quik M, Cox H, Parameswaran N, O’Leary K, Langston JW, Di Monte D. (2007). Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys. Ann Neurol 62:588–596.
  • Quik M, Parameswaran N, McCallum SE, Bordia T, Bao S, McCormack A, Kim A, Tyndale RF, Langston JW, Di Monte DA. (2006). Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates. J Neurochem 98:1866–1875.
  • Razani-Boroujerdi S, Boyd RT, Davila-Garcia MI., Nandi JS, Mishra NC, Singh SP, Pena-Philippides JC, Langley R, Sopori ML. (2007). T cells express alpha7-nicotinic acetylcholine receptor subunits that require a functional TCR and leukocyte-specific protein tyrosine kinase for nicotine-induced Ca2+ response. J Immunol 179:2889–2898.
  • Rehan VK, Asotra K, Torday JS. (2009). The effects of smoking on the developing lung: insights from a biologic model for lung development, homeostasis, and repair. Lung 187:281–289.
  • Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA, Ross GW, Strickland D, Van Den Eeden SK, Gorell J. (2007). Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol 64:990–997.
  • Roman J, Ritzenthaler JD, Gil-Acosta A, Rivera HN, Roser-Page S. (2004). Nicotine and fibronectin expression in lung fibroblasts: implications for tobacco-related lung tissue remodeling. FASEB J 18:1436–1438.
  • Rothem DE, Rothem L, Soudry M, Dahan A, Eliakim R. (2009). Nicotine modulates bone metabolism-associated gene expression in osteoblast cells. J Bone Miner Metab 27:555–561.
  • Russo P, Catassi A, Cesario A, Servent D. (2006). Development of novel therapeutic strategies for lung cancer: targeting the cholinergic system. Curr Med Chem 13:3493–3512.
  • Russo P, Cesario A, Rutella S, Veronesi G, Spaggiari L, Galetta D, Margaritora S, Granone P, Greenberg DS. (2011). Impact of genetic variability in nicotinic acetylcholine receptors on nicotine addiction and smoking cessation treatment. Curr Med Chem 18:91–112.
  • Russo P, Nastrucci C, Cardinale A, Granone P, Cesario A. (2012). Nicotinic receptor and tobacco related cancer. Life Sciences in press.
  • Sahai E. (2005). Mechanisms of cancer cell invasion. Curr Opin Genet Dev 15:87–96.
  • Sahakian BJ, Coull JT. (1994). Nicotine and tetrahydroaminoacradine: Evidence for improved attention in patients with dementia of the Alzheimer type Drug Dev Res 31:80–88.
  • Sarter M, Hasselmo ME, Bruno JP, Givens B. (2005). Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection. Brain Res Brain Res Rev 48:98–111.
  • Schneider NG, Olmstead RE, Franzon MA, Lunell E. (2001). The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments. Clin Pharmacokinet 40:661–684.
  • Schroeder KM, Wu J, Zhao L, Lukas RJ. (2003). Regulation by cycloheximide and lowered temperature of cell-surface alpha7-nicotinic acetylcholine receptor expression on transfected SH-EP1 cells. J Neurochem 85:581–591.
  • Schuller HM. (2009). Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat Rev Cancer 9:195–205.
  • Schuller HM, Al-Wadei HA. (2010). Neurotransmitter receptors as central regulators of pancreatic cancer. Future Oncol 6:221–228.
  • Schuller HM. (2008). Neurotransmission and cancer: implications for prevention and therapy. Anticancer Drugs 19:655–671.
  • Sharma G, Grybko M, Vijayaraghavan S. (2008). Action potential-independent and nicotinic receptor-mediated concerted release of multiple quanta at hippocampal CA3-mossy fiber synapses. J Neurosci 28:2563–2575.
  • Shaw S, Bencherif M, Marrero MB. (2002). Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1-42) amyloid. J Biol Chem 277:44920–44924.
  • Shaw S, Bencherif M, Marrero MB. (2003). Angiotensin II blocks nicotine-mediated neuroprotection against beta-amyloid (1-42) via activation of the tyrosine phosphatase SHP-1. J Neurosci 23:11224–11228.
  • Shin VY, Jin HC, Ng EK, Sung JJ, Chu KM, Cho CH. (2010). Activation of 5-lipoxygenase is required for nicotine mediated epithelial-mesenchymal transition and tumor cell growth. Cancer Lett 292:237–245.
  • Shin VY, Wu WK, Chu KM, Wong HP, Lam EK, Tai EK, Koo MW, Cho CH. (2005). Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer. Mol Cancer Res 3:607–615.
  • Shin VY, Wu WK, Ye YN, So WH, Koo MW, Liu ES, Luo JC, Cho CH. (2004). Nicotine promotes gastric tumor growth and neovascularization by activating extracellular signal-regulated kinase and cyclooxygenase-2. Carcinogenesis 25:2487–2495.
  • Silman AJ, Newman J, MacGregor AJ. (1996). Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins. Arthritis Rheum 39:732–735.
  • Slotkin TA. (1998). Fetal nicotine or cocaine exposure: which one is worse? J Pharmacol Exp Ther 285:931–945.
  • Slotkin TA, Epps TA, Stenger ML, Sawyer KJ, Seidler FJ. (1999). Cholinergic receptors in heart and brainstem of rats exposed to nicotine during development: implications for hypoxia tolerance and perinatal mortality. Brain Res Dev Brain Res 113:1–12.
  • Song P, Spindel ER. (2008). Basic and clinical aspects of non-neuronal acetylcholine: expression of non-neuronal acetylcholine in lung cancer provides a new target for cancer therapy. J Pharmacol Sci 106:180–185.
  • Srivareerat M, Tran TT, Salim S, Aleisa AM, Alkadhi KA. (2011). Chronic nicotine restores normal Aß levels and prevents short-term memory and E-LTP impairment in Aß rat model of Alzheimer’s disease. Neurobiol Aging 32:834–844.
  • Strathdee G. (2002). Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin Cancer Biol 12:373–379.
  • Sugano N, Ito K. (2000). Nicotine switches the form of H(2)O(2)-induced cell death from apoptosis to necrosis in U937 cells. Immunol Lett 72:163–166.
  • Sugano N, Minegishi T, Kawamoto K, Ito K. (2001). Nicotine inhibits UV-induced activation of the apoptotic pathway. Toxicol Lett 125:61–65.
  • Sugiyama D, Nishimura K, Tamaki K, Tsuji G, Nakazawa T, Morinobu A, Kumagai S. (2010). Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 69:70–81.
  • Sun X, Ritzenthaler JD, Zhong X, Zheng Y, Roman J, Han S. (2009). Nicotine stimulates PPARbeta/delta expression in human lung carcinoma cells through activation of PI3K/mTOR and suppression of AP-2alpha. Cancer Res 69:6445–6453.
  • Swan GE, Lessov-Schlaggar CN. (2007). The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev 17:259–273.
  • Szabo SI, Zelles T, Lendvai B. (2008). Intracellular Ca2+ dynamics of hippocampal interneurons following nicotinic acetylcholine receptor activation. Neurochem Int 52:135–141.
  • Szekanecz Z, Koch AE. (2007). Macrophages and their products in rheumatoid arthritis. Curr Opin Rheumatol 19:289–295.
  • Tager IB, Weiss ST, Muñoz A, Rosner B, Speizer FE. (1983). Longitudinal study of the effects of maternal smoking on pulmonary function in children. N Engl J Med 309:699–703.
  • Taly A, Corringer PJ, Guedin D, Lestage P, Changeux JP. (2009). Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system. Nat Rev Drug Discov 8:733–750.
  • Tariq M, Khan HA, Elfaki I, Al Deeb S, Al Moutaery K. (2005). Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington’s disease in rats. Brain Res Bull 67:161–168.
  • Terry AV Jr, Decker MW. (2011). Neurobiology of nAChRs and cognition: A mini review of Dr. Jerry J. Buccafusco’s contributions over a 25 year career. Biochem Pharmacol 82:883–890.
  • Terzano S, Court JA, Fornasari D, Griffiths M, Spurden DP, Lloyd S, Perry RH, Perry EK, Clementi F. (1998). Expression of the alpha3 nicotinic receptor subunit mRNA in aging and Alzheimer’s disease. Brain Res Mol Brain Res 63:72–78.
  • Thacker EL, O’Reilly EJ, Weisskopf MG, Chen H, Schwarzschild MA, McCullough ML, Calle EE, Thun MJ, Ascherio A. (2007). Temporal relationship between cigarette smoking and risk of Parkinson disease. Neurology 68:764–768.
  • Thiery JP, Sleeman JP. (2006). Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7:131–142.
  • Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. (2005). Smoking and age-related macular degeneration: a review of association. Eye (Lond) 19:935–944.
  • Thunnissen FB. (2009). Acetylcholine receptor pathway and lung cancer. J Thorac Oncol 4:943–946.
  • Trombino S, Cesario A, Margaritora S, Granone P, Motta G, Falugi C, Russo P. (2004). Alpha7-nicotinic acetylcholine receptors affect growth regulation of human mesothelioma cells: role of mitogen-activated protein kinase pathway. Cancer Res 64:135–145.
  • Tsurutani J, Castillo SS, Brognard J, Granville CA, Zhang C, Gills JJ, Sayyah J, Dennis PA. (2005). Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. Carcinogenesis 26:1182–1195.
  • Ulrich J, Johannson-Locher G, Seiler WO, Stähelin HB. (1997). Does smoking protect from Alzheimer’s disease? Alzheimer-type changes in 301 unselected brains from patients with known smoking history. Acta Neuropathol 94:450–454.
  • Vallejo YF, Buisson B, Bertrand D, Green WN. (2005). Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism. J Neurosci 25:5563–5572.
  • Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. (2001). Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89:E1–E7.
  • Videtic GM, Stitt LW, Dar AR, Kocha WI, Tomiak AT, Truong PT, Vincent MD, Yu EW. (2003). Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. J Clin Oncol 21:1544–1549.
  • Villablanca AC. (1998). Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro. J Appl Physiol 84:2089–2098.
  • Viswanath K, Herbst RS, Land SR, Leischow SJ, Shields PG; Writing Committee for the AACR Task Force on Tobacco and Cancer. (2010). Tobacco and cancer: an American Association for Cancer Research policy statement. Cancer Res 70:3419–3430.
  • von Ziegler NI, Schlumpf M, Lichtensteiger W. (1991). Prenatal nicotine exposure selectively affects perinatal forebrain aromatase activity and fetal adrenal function in male rats. Brain Res Dev Brain Res 62:23–31.
  • Waggoner LE, Dickinson KA, Poole DS, Tabuse Y, Miwa J, Schafer WR. (2000). Long-term nicotine adaptation in Caenorhabditis elegans involves PKC-dependent changes in nicotinic receptor abundance. J Neurosci 20:8802–8811.
  • Waldburger JM, Boyle DL, Pavlov VA, Tracey KJ, Firestein GS. (2008). Acetylcholine regulation of synoviocyte cytokine expression by the alpha7 nicotinic receptor. Arthritis Rheum 58:3439–3449.
  • Walker LM, Preston MR, Magnay JL, Thomas PB, El Haj AJ. (2001). Nicotinic regulation of c-fos and osteopontin expression in human-derived osteoblast-like cells and human trabecular bone organ culture. Bone 28:603–608.
  • Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, Al-Abed Y, Wang H, Metz C, Miller EJ, Tracey KJ, Ulloa L. (2004). Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10:1216–1221.
  • Wang H, Sun X. (2005). Desensitized nicotinic receptors in brain. Brain Res Brain Res Rev 48:420–437.
  • Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ. (2003a). Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421:384–388.
  • Wang HY, Lee DH, D’Andrea MR, Peterson PA, Shank RP, Reitz AB. (2000). beta- Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer’s disease pathology. J Biol Chem 275:5626–5632.
  • Wang HY, Li W, Benedetti NJ, Lee DH. (2003b). Alpha 7 nicotinic acetylcholine receptors mediate beta-amyloid peptide-induced tau protein phosphorylation. J Biol Chem 278:31547–31553.
  • Wang J, Horenstein NA, Stokes C, Papke RL. (2010). Tethered agonist analogs as site-specific probes for domains of the human a7 nicotinic acetylcholine receptor that differentially regulate activation and desensitization. Mol Pharmacol 78:1012–1025.
  • Wang Y, Pereira EF, Maus AD, Ostlie NS, Navaneetham D, Lei S, Albuquerque EX, Conti-Fine BM. (2001). Human bronchial epithelial and endothelial cells express alpha7 nicotinic acetylcholine receptors. Mol Pharmacol 60:1201–1209.
  • Warburton DM. (1992). Nicotine as a cognitive enhancer. Prog Neuropsychopharmacol Biol Psychiatry 16:181–191.
  • Wassenaar CA, Dong Q, Wei Q, Amos CI, Spitz MR, Tyndale RF. (2011). Relationship Between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 Variation and Smoking Behaviors and Lung Cancer Risk. J Natl Cancer Inst 103:1342–1346.
  • Wathey JC, Nass MM, Lester HA. (1979). Numerical reconstruction of the quantal event at nicotinic synapses. Biophys J 27:145–164.
  • Wessler I, Kirkpatrick CJ, Racké K. (1999). The cholinergic ‘pitfall’: acetylcholine, a universal cell molecule in biological systems, including humans. Clin Exp Pharmacol Physiol 26:198–205.
  • Wessler I, Kirkpatrick CJ. (2008). Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol 154:1558–1571.
  • West KA, Brognard J, Clark AS, Linnoila IR, Yang X, Swain SM, Harris C, Belinsky S, Dennis PA. (2003). Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 111:81–90.
  • Westman M, Engström M, Catrina AI, Lampa J. (2009). Cell specific synovial expression of nicotinic alpha 7 acetylcholine receptor in rheumatoid arthritis and psoriatic arthritis. Scand J Immunol 70:136–140.
  • Winterer G, Mittelstrass K, Giegling I, Lamina C, Fehr C, Brenner H, Breitling LP, Nitz B, Raum E, Müller H, Gallinat J, Gal A, Heim K, Prokisch H, Meitinger T, Hartmann AM, Möller HJ, Gieger C, Wichmann HE, Illig T, Dahmen N, Rujescu D. (2010). Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance. Am J Med Genet B Neuropsychiatr Genet 153B:1448–1458.
  • Wong HP, Yu L, Lam EK, Tai EK, Wu WK, Cho CH. (2007a). Nicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activation. Toxicol Sci 97:279–287.
  • Wong HP, Yu L, Lam EK, Tai EK, Wu WK, Cho CH. (2007b). Nicotine promotes cell proliferation via alpha7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymes-mediated pathway in human colon adenocarcinoma HT-29 cells. Toxicol Appl Pharmacol 221:261–267.
  • World Health Organization. Tobacco key facts. [cited October 31, 2009] http://www.who.int/topics/tobacco/facts/en/index.html. Accessed March 29, 2010].
  • Wouters BG, Koritzinsky M. (2008). Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer 8:851–864.
  • Wu JC, Chruscinski A, De Jesus Perez VA, Singh H, Pitsiouni M, Rabinovitch M, Utz PJ, Cooke JP. (2009). Cholinergic modulation of angiogenesis: role of the 7 nicotinic acetylcholine receptor. J Cell Biochem 108:433–446.
  • Xin M, Deng X. (2005). Nicotine inactivation of the proapoptotic function of Bax through phosphorylation. J Biol Chem 280:10781–10789.
  • Xu L, Deng X. (2006). Protein kinase Ciota promotes nicotine-induced migration and invasion of cancer cells via phosphorylation of micro- and m-calpains. J Biol Chem 281:4457–4466.
  • Yoshida M, Inadome A, Maeda Y, Satoji Y, Masunaga K, Sugiyama Y, Murakami S. (2006). Non-neuronal cholinergic system in human bladder urothelium Urology 67:425–430.
  • Yu J, Huang NF, Wilson KD, Velotta JB, Huang M, Li Z, Lee A, Robbins RC, Cooke JP, Wu JC. (2009). nAChRs mediate human embryonic stem cell-derived endothelial cells: proliferation, apoptosis, and angiogenesis. PLoS ONE 4:e7040.
  • Zeidler R, Albermann K, Lang S. (2007). Nicotine and apoptosis. Apoptosis 12:1927–1943.
  • Zhang J, Kamdar O, Le W, Rosen GD, Upadhyay D. (2009). Nicotine induces resistance to chemotherapy by modulating mitochondrial signaling in lung cancer. Am J Respir Cell Mol Biol 40:135–146.
  • Zhang Q, Tang X, Zhang ZF, Velikina R, Shi S, Le AD. (2007). Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways. Clin Cancer Res 13:4686–4694.
  • Zhang T, Lu H, Shang X, Tian Y, Zheng C, Wang S, Cheng H, Zhou R. (2006). Nicotine prevents the apoptosis induced by menadione in human lung cancer cells. Biochem Biophys Res Commun 342:928–934.
  • Zhao J, Xin M, Wang T, Zhang Y, Deng X. (2009). Nicotine enhances the antiapoptotic function of Mcl-1 through phosphorylation. Mol Cancer Res 7:1954–1961.
  • Zheng Y, Ritzenthaler JD, Roman J, Han S. (2007). Nicotine stimulates human lung cancer cell growth by inducing fibronectin expression. Am J Respir Cell Mol Biol 37:681–690.
  • Zhu BQ, Heeschen C, Sievers RE, Karliner JS, Parmley WW, Glantz SA, Cooke JP. (2003). Second hand smoke stimulates tumor angiogenesis and growth. Cancer Cell 4:191–196.
  • Zia S, Ndoye A, Grando S. (1999). Nicotine reduces keratinocyte migration distance by altering intracellular calcium levels via receptor-mediated pathway. J Invest Dermatol 112:613–618.
  • Zong Y, Zhang ST, Zhu ST. (2009). Nicotine enhances migration and invasion of human esophageal squamous carcinoma cells which is inhibited by nimesulide. World J Gastroenterol 15:2500–2505.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.